Primecap Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-30,000
| Closed | -$262K | – | 346 |
|
|
2025
Q1 | $262K | Sell |
30,000
-97,600
| -76% | -$852K | ﹤0.01% | 332 |
|
|
2024
Q4 | $1.83M | Sell |
127,600
-167,800
| -57% | -$2.41M | ﹤0.01% | 307 |
|
|
2024
Q3 | $6.67M | Buy |
295,400
+108,600
| +58% | +$2.45M | ﹤0.01% | 276 |
|
|
2024
Q2 | $3.63M | Buy |
186,800
+107,400
| +135% | +$2.09M | ﹤0.01% | 292 |
|
|
2024
Q1 | $2.98M | Buy |
79,400
+48,000
| +153% | +$1.8M | ﹤0.01% | 301 |
|
|
2023
Q4 | $1.76M | Buy |
31,400
+1,300
| +4% | +$72.7K | ﹤0.01% | 313 |
|
|
2023
Q3 | $1.24M | Buy |
+30,100
| New | +$1.24M | ﹤0.01% | 314 |
|
|
2022
Q2 | – | Sell |
-3,300
| Closed | -$251K | – | 343 |
|
|
2022
Q1 | $251K | Hold |
3,300
| – | – | ﹤0.01% | 337 |
|
|
2021
Q4 | $492K | Sell |
3,300
-4,350
| -57% | -$649K | ﹤0.01% | 338 |
|
|
2021
Q3 | $1.11M | Hold |
7,650
| – | – | ﹤0.01% | 328 |
|
|
2021
Q2 | $1.5M | Hold |
7,650
| – | – | ﹤0.01% | 321 |
|
|
2021
Q1 | $1.39M | Hold |
7,650
| – | – | ﹤0.01% | 318 |
|
|
2020
Q4 | $1.08M | Hold |
7,650
| – | – | ﹤0.01% | 312 |
|
|
2020
Q3 | $954K | Hold |
7,650
| – | – | ﹤0.01% | 303 |
|
|
2020
Q2 | $683K | Hold |
7,650
| – | – | ﹤0.01% | 298 |
|
|
2020
Q1 | $477K | Buy |
+7,650
| New | +$477K | ﹤0.01% | 285 |
|